EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development of heparinized and hepatocyte growth factor‐coated acellular scaffolds using porcine carotid arteries

Jin Cheng, Cong Wang, Lianrui Guo, Yongquan Gu iD

Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2024

DOI: 10.1002/jbm.b.35317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2024. Verfasst von Jin Cheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Tissue Scaffolds, Hepatocyte Growth Factor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, Training Fund for Open Projects at Clinical Institutes and Departments of Capital Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tissue‐engineered blood vessel substitutes have been developed due to the lack of suitable small‐diameter vascular grafts. Xenogeneic extracellular matrix (ECM) scaffolds have the potential to provide an ideal source for off‐the‐shelf vascular grafts. In this study, porcine carotid arteries were used to develop ECM scaffolds by decellularization and coating with heparin and hepatocyte growth factor (HGF). After decellularization, cellular and nucleic materials were successfully removed with preservation of the main compositions (collagen, elastin, and basement membrane) of the native ECM. The ultimate tensile strength, suture strength, and burst pressure were significantly increased after cross‐linking. Pore size distribution analysis revealed a porous structure within ECM scaffolds with a high distribution of pores larger than 10 μm. Heparinized scaffolds exhibited sustained release of heparin in vitro and showed potent anticoagulant activity by prolonging activated partial thromboplastin time. The scaffolds showed an enhanced HGF binding capacity as well as a constant release of HGF as a result of heparin modification. When implanted subcutaneously in rats, the modified scaffolds revealed good biocompatibility with enzyme degradation resistance, mitigated immune response, and anti‐calcification. In conclusion, heparinized and HGF‐coated acellular porcine carotid arteries may be a promising biological scaffold for tissue‐engineered vascular grafts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tissue ScaffoldsHepatocyte Growth FactorSwineRatsAnimalsTissue EngineeringCarotid ArteriesBlood Vessel ProsthesisHeparinExtracellular Matrix

Stichwörter der Autor:innen

acellular scaffoldscross-linkingheparinhepatocyte growth factortissue-engineered vascular grafts

Substanzen

Hepatocyte Growth FactorHeparin

Autor:innen und Institutionen

  • Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China.

ORCID-Profile: Yongquan Gu

Förderung

  • National Key Research and Development Program of China
  • Training Fund for Open Projects at Clinical Institutes and Departments of Capital Medical University

Zitieren

APA

Cheng, J., Wang, C., Guo, L., & Gu, Y. (2024). Development of heparinized and hepatocyte growth factor‐coated acellular scaffolds using porcine carotid arteries. Journal of Biomedical Materials Research Part B: Applied Biomaterials. https://doi.org/10.1002/jbm.b.35317

Vancouver

Cheng J, Wang C, Guo L, Gu Y. Development of heparinized and hepatocyte growth factor‐coated acellular scaffolds using porcine carotid arteries. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2024. doi:10.1002/jbm.b.35317

BibTeX
@article{Cheng2024,
  author = {Cheng, Jin and Wang, Cong and Guo, Lianrui and Gu, Yongquan},
  title = {Development of heparinized and hepatocyte growth factor‐coated acellular scaffolds using porcine carotid arteries},
  journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
  year = {2024},
  doi = {10.1002/jbm.b.35317}
}
Kostenlos starten →